Loading…
Loading…
EQUITY / NASDAQ · XNCM
Ping An Biomedical Co., Ltd.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →10/01/2024 – 09/30/2025 · CNY · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.1248 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 0.1248 USD · Volume 62,149
250 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
10/01/2024 – 09/30/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 34,147,936 CNY | 87,622,395 CNY | -61.03% |
| Operating profit | -14,701,471 CNY | -2,039 CNY | — |
| Net income | -12,829,206 CNY | -1,284,172 CNY | — |
| Operating cash flow | -6,427,762 CNY | 14,630,221 CNY | -143.93% |
| Cash and cash equivalents | 1,172,480 CNY | 130,923 CNY | +795.55% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end10/01/2024 – 09/30/2025ConsolidatedUnits · CNY | 2024 / Year end10/01/2023 – 09/30/2024ConsolidatedUnits · CNY | 2023 / Year end10/01/2022 – 09/30/2023ConsolidatedUnits · CNY |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 1,172,480 CNY | 130,923 CNY | 591,874 CNY |
| Financing cash flowCash flow statement | 43,660,424 CNY | -30,088,905 CNY | 8,874,664 CNY |
| Gross profitIncome statement | 949,505 CNY | 5,416,887 CNY | 4,240,168 CNY |
| Investing cash flowCash flow statement | 0 CNY | 15,000,000 CNY | -3,367,570 CNY |
| Net incomeIncome statement | -12,829,206 CNY | -1,284,172 CNY | -993,937 CNY |
| Operating cash flowCash flow statement | -6,427,762 CNY | 14,630,221 CNY | -6,082,836 CNY |
| Operating profitIncome statement | -14,701,471 CNY | -2,039 CNY | 612,481 CNY |
| RevenueIncome statement | 34,147,936 CNY | 87,622,395 CNY | 82,563,751 CNY |
| Total assetsBalance sheet | 68,414,527 CNY | 56,849,755 CNY | — |
| Total equityBalance sheet | 45,242,007 CNY | -7,188,181 CNY | -5,859,593 CNY |
| Total liabilitiesBalance sheet | 23,172,520 CNY | 64,037,936 CNY | — |
| Report source | Open report ↗ Published: 01/30/2026 | Open report ↗ Published: 01/30/2026 | Open report ↗ Published: 01/30/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.